Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³. - Wikidata - wikimedia - TriplyDB

Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³.

Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³.

http://www.wikidata.org/entity/Q37025746

about

Monocytes as regulators of inflammation and HIV-related comorbidities during cART Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers Delayed-type hypersensitivity and hepatitis B vaccine responses, in vivo markers of cellular and humoral immune function, and the risk of AIDS or death Can early therapy reduce inflammation?Morbidity and mortality according to latest CD4+ cell count among HIV positive individuals in South Africa who enrolled in project Phidisa Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature.History of AIDS in HIV-Infected Patients Is Associated With Higher In-Hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke Serious Non-AIDS events: Immunopathogenesis and interventional strategies.Cardiovascular disease and HIV infection.Analysis of Non-AIDS-Defining Events in HIV Controllers.Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach.Current Treatment Options for HIV Elite Controllers: a Review

P2860

Q27006827-2869EA41-C50B-4805-9DE1-851AA3B2AE71 Q27014077-33A8C914-8893-4DF5-AD7C-C2F908CA1845 Q33649200-F3CB2214-E03F-44F5-AF5F-3C136A66AE51 Q33828507-2DA34EAE-B745-4744-826B-3F873E8CF051 Q33966170-39C97875-554B-408B-87A4-A5E5650FCA6C Q34159822-15B3D819-F15D-4E93-9C3E-CE099A0894B5 Q35345807-9BB679CD-F6E8-40B2-B461-39B26827D4C0 Q35661912-746E9E04-41E9-4B97-AEAA-78F47C68EEAC Q36833017-31B3566A-052F-4FCE-84AF-85B1F777A465 Q36931801-BE3F0320-7E79-46E1-9209-41AD9603BDC5 Q37418140-D885C189-1992-49AD-905F-D726542039F2 Q37661603-6264A644-F6BF-41FF-96BE-F04F099ABE6E Q39952253-BCD75C23-58DA-4C84-958B-4FFB8FD9D9D5 Q40060299-F40F734A-06BD-4B37-97CC-C3EDA37A7891 Q57825309-7C746AAE-57F6-4437-8175-9B0F90507D0F

P2860

Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³.

http://www.wikidata.org/entity/Q37025746

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Rate and predictors of non-AID ...... ell count above 500 cells/mm³.

@en

Rate and predictors of non-AID ...... ell count above 500 cells/mm³.

@nl

type

label

Rate and predictors of non-AID ...... ell count above 500 cells/mm³.

@en

Rate and predictors of non-AID ...... ell count above 500 cells/mm³.

@nl

prefLabel

Rate and predictors of non-AID ...... ell count above 500 cells/mm³.

@en

Rate and predictors of non-AID ...... ell count above 500 cells/mm³.

@nl

P1433

Q37025746-E479927C-CCC0-4806-9C76-4ED0C087F06E

P1476

Q37025746-A746D51D-5971-47D1-8234-F1840ADC02D2

P2093

Q37025746-3C2946C8-9C46-4AA8-B7DF-F5064F55B970

Q37025746-60F945AA-9BF1-42EE-B14C-2150AB0703F7

Q37025746-7D73762A-C099-4A69-988D-0D6F435E4AD8

Q37025746-84827CCB-4C52-4ACA-A2D9-F2735028852F

Q37025746-A7AFBF40-67EA-4AC0-AF27-2A0A4D828804

Q37025746-B0DDD699-9ED3-4ED4-95E4-8D68642DEEA6

Q37025746-BB17ED44-612C-4736-9C73-7392C758C62E

Q37025746-BCF9E65D-6A1F-49E2-9A87-12D0F256D1D1

Q37025746-BD0BBAED-554F-4C7B-BC24-8A99670BB32F

P2860

Q37025746-22BC2EF0-7E45-4F18-A467-1B5E5344D5D4

Q37025746-2687304F-B402-40C4-A07E-91831F4AD3CB

Q37025746-2B7C8CE5-9A15-45F3-A793-A841BC915D9C

Q37025746-2EF5FAB6-4BA0-4A65-BA71-45CC6498CC9B

Q37025746-2F2D929E-6330-4BB4-8FFA-53FC4F7DE46E

Q37025746-43E9A94A-7773-48FE-A11A-913E002AA78F

Q37025746-52A84525-94DF-45D9-B3FC-0C40D2BF284E

Q37025746-59B7EDC0-89D5-4BA9-9F30-CFDF0C939D50

Q37025746-5DDD3CCA-584A-4409-AC43-8289D12BF285

Q37025746-62EE3FB4-F456-44D0-935E-80B72E15EED2

P304

Q37025746-E4DEAC5F-A2C9-40CE-B7AB-E048254DE2F0

P31

Q37025746-B75D0AC4-9C20-4319-B113-BBB4BE3CD38E

P356

Q37025746-444DCEA3-1530-4BBE-B860-9B5AF0F3E23A

P433

Q37025746-129BF7CE-08E8-4BE3-BFC2-D1F1716A4493

P478

Q37025746-8EB9DA78-D860-43FB-BB06-4E24D7F6AFC7

P50

Q37025746-54EF3BF5-0D49-44B2-BD57-40F6178EE52B

Q37025746-AA3F149E-237F-4C02-8E85-40F1189B0D44

P577

Q37025746-B6069B78-1C2E-492E-AB40-D44C4F71AC15

P698

Q37025746-83DD57B8-470E-4F5B-97D1-8A5DD0F8A174

P921

Q37025746-8A251748-2CFA-49AE-8D17-EFCC969AA7C9

P932

Q37025746-2E057350-E8E2-4FD0-A704-304B177BFBB9

P356

P1433

AIDS Research and Human Retroviruses

P1476

Rate and predictors of non-AID ...... ell count above 500 cells/mm³.

@en

P2093

Berta Torres

http://www.w3.org/2001/XMLSchema#string

Constanza Lucero

http://www.w3.org/2001/XMLSchema#string

Iñaki Pérez

http://www.w3.org/2001/XMLSchema#string

Josep M Gatell

http://www.w3.org/2001/XMLSchema#string

Josep Mallolas

http://www.w3.org/2001/XMLSchema#string

Lorna Leal

http://www.w3.org/2001/XMLSchema#string

Marta Calvo

http://www.w3.org/2001/XMLSchema#string

Mireia Arnedo

http://www.w3.org/2001/XMLSchema#string

Montserrat Plana

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Prevention of HIV-1 infection with early antiretroviral therapy

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

CD4+ count-guided interruption of antiretroviral treatment

Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.

HIV infection and the risk of cancers with and without a known infectious cause.

Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

P304

1161-1167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/AID.2012.0367

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23530980

http://www.w3.org/2001/XMLSchema#string

P921

P932

3715811

http://www.w3.org/2001/XMLSchema#string